People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ruby Bio, Inc. | — | Biotech / Pharma | Series A | $13.1M | $27.7M | 2025 |
Kevin Yanos at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kevin Yanos on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| CHARLES SILVER | 1 | 3 |
| Brian Rigert | 1 | 2 |
| Vaibhav Kumar | 1 | 2 |
| Pavan Kambam | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.